CERTARA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.92 USD | -1.00% |
|
-5.41% | -8.58% |
| May. 15 | Transcript : Certara, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:40 PM | |
| May. 08 | Certara Q1 Adjusted Earnings Down, Revenue Increases | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,158 | 4,538 | 2,566 | 2,812 | 2,586 | - | - |
| Enterprise Value (EV) 1 | 5,186 | 4,655 | 2,622 | 2,868 | 2,577 | 2,490 | 2,399 |
| P/E ratio | -91.1 x | -316 x | 179 x | -50.3 x | - | 210 x | 169 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 21.2 x | 15.9 x | 7.64 x | 7.94 x | 6.62 x | 6.01 x | 5.5 x |
| EV / Revenue | 21.3 x | 16.3 x | 7.81 x | 8.09 x | 6.6 x | 5.79 x | 5.1 x |
| EV / EBITDA | 59 x | 44.9 x | 21.8 x | 23.3 x | 20.8 x | 17.5 x | 15.2 x |
| EV / FCF | 118 x | 78.6 x | 28.8 x | 35.4 x | 34.3 x | 34 x | - |
| FCF Yield | 0.85% | 1.27% | 3.47% | 2.82% | 2.92% | 2.94% | - |
| Price to Book | 6.27 x | 4.36 x | 2.37 x | 2.69 x | 2.32 x | 2.21 x | 2.07 x |
| Nbr of stocks (in thousands) | 152,979 | 159,659 | 159,673 | 159,845 | 160,841 | - | - |
| Reference price 2 | 33.72 | 28.42 | 16.07 | 17.59 | 16.08 | 16.08 | 16.08 |
| Announcement Date | 3/4/21 | 3/1/22 | 3/1/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 208.5 | 243.5 | 286.1 | 335.6 | 354.3 | 390.7 | 430.1 | 470.6 |
| EBITDA 1 | - | 87.88 | 103.7 | 120.2 | 123.1 | 123.9 | 142 | 158.1 |
| EBIT 1 | - | 48.02 | 62.86 | 67.7 | 67.04 | 111.5 | 129.1 | 145.2 |
| Operating Margin | - | 19.72% | 21.97% | 20.17% | 18.92% | 28.53% | 30.01% | 30.86% |
| Earnings before Tax (EBT) 1 | - | -50.18 | -3.375 | 18.76 | -55.14 | -9.93 | 15.91 | 39.42 |
| Net income 1 | - | -49.4 | -13.27 | 14.73 | -55.36 | -6.895 | 5.287 | 15.39 |
| Net margin | - | -20.28% | -4.64% | 4.39% | -15.62% | -1.76% | 1.23% | 3.27% |
| EPS 2 | - | -0.3700 | -0.0900 | 0.0900 | -0.3500 | - | 0.0767 | 0.0950 |
| Free Cash Flow 1 | - | 43.95 | 59.24 | 91.11 | 80.98 | 75.22 | 73.3 | - |
| FCF margin | - | 18.05% | 20.71% | 27.15% | 22.85% | 19.25% | 17.04% | - |
| FCF Conversion (EBITDA) | - | 50.01% | 57.12% | 75.82% | 65.78% | 60.72% | 51.62% | - |
| FCF Conversion (Net income) | - | - | - | 618.51% | - | - | 1,386.47% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 11/18/20 | 3/4/21 | 3/1/22 | 3/1/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 75.35 | 81.55 | 82.76 | 84.7 | 86.63 | 90.3 | 90.45 | 85.58 | 88.01 | 96.65 | 96.28 | 96.9 | 101.2 | 105.3 | 107.6 |
| EBITDA 1 | 28.18 | 27.65 | 27.96 | 32.7 | 31.86 | 32.31 | 32.37 | 28.84 | 29.58 | 29.14 | 29.8 | 31.03 | 33.9 | 34.56 | 34.8 |
| EBIT 1 | 17.55 | 14.72 | 14.83 | 19.44 | 18.72 | 18.78 | 18.84 | 14.66 | 14.75 | 12.72 | 27.07 | 28.79 | 30.4 | 30.74 | 32 |
| Operating Margin | 23.29% | 18.05% | 17.91% | 22.95% | 21.61% | 20.8% | 20.83% | 17.14% | 16.76% | 13.16% | 28.12% | 29.71% | 30.04% | 29.21% | 29.75% |
| Earnings before Tax (EBT) | -0.157 | 3.746 | 2.791 | 8.493 | 3.725 | - | 8.381 | - | - | - | - | - | - | - | - |
| Net income 1 | -9.699 | 2.21 | -0.589 | 3.936 | 9.174 | 1.358 | 4.706 | -48.96 | -12.46 | - | -2.821 | -2.769 | -0.826 | -0.4 | -0.3 |
| Net margin | -12.87% | 2.71% | -0.71% | 4.65% | 10.59% | 1.5% | 5.2% | -57.22% | -14.15% | - | -2.93% | -2.86% | -0.82% | -0.38% | -0.28% |
| EPS 2 | -0.0600 | 0.0100 | -0.003800 | 0.0200 | 0.0600 | 0.0100 | 0.0300 | -0.3100 | -0.0800 | -0.0300 | - | -0.005000 | 0.005000 | 0.0300 | 0.0300 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/1/22 | 5/5/22 | 8/9/22 | 11/7/22 | 3/1/23 | 5/8/23 | 8/9/23 | 11/8/23 | 2/29/24 | 5/7/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | 28 | 117 | 56.4 | 56.3 | - | - | - |
| Net Cash position 1 | - | - | - | - | - | 9.29 | 96.5 | 188 |
| Leverage (Debt/EBITDA) | - | 0.3185 x | 1.13 x | 0.4695 x | 0.4572 x | - | - | - |
| Free Cash Flow 1 | - | 43.9 | 59.2 | 91.1 | 81 | 75.2 | 73.3 | - |
| ROE (net income / shareholders' equity) | - | 3.35% | 2.77% | 6.92% | 6.49% | 6.65% | 7.37% | 8.06% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | 5.370 | 6.530 | 6.770 | 6.550 | 6.940 | 7.290 | 7.780 |
| Cash Flow per Share 2 | - | 0.3400 | 0.4000 | 0.5800 | 0.5200 | 0.8100 | 0.8800 | - |
| Capex 1 | - | 0.86 | 1.14 | 1.43 | 1.78 | 2.1 | 1.7 | - |
| Capex / Sales | - | 0.35% | 0.4% | 0.43% | 0.5% | 0.54% | 0.4% | - |
| Announcement Date | 11/18/20 | 3/4/21 | 3/1/22 | 3/1/23 | 2/29/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
16.08
USD
Average target price
19.72
USD
Spread / Average Target
+22.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.58% | 2.59B | |
| +11.75% | 3,123B | |
| +10.06% | 86.45B | |
| +6.04% | 78.6B | |
| -14.48% | 53.99B | |
| +26.73% | 48.46B | |
| -24.44% | 46.78B | |
| +31.74% | 46.36B | |
| +82.12% | 42.36B | |
| -8.15% | 25.25B |
- Stock Market
- Equities
- CERT Stock
- Financials Certara, Inc.
